Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Psyence Biomedical Ltd (NASDAQ: PBM) closed the day trading at $0.44 down -3.59% from the previous closing price of $0.46. In other words, the price has decreased by -$3.59 from its previous closing price. On the day, 0.53 million shares were traded. PBM stock price reached its highest trading level at $0.46 during the session, while it also had its lowest trading level at $0.3743.
Ratios:
For a better understanding of PBM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.64 and its Current Ratio is at 0.64.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBM now has a Market Capitalization of 1991937 and an Enterprise Value of -364826.
Stock Price History:
The Beta on a monthly basis for PBM is -0.11, which has changed by -0.99494255 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, PBM has reached a high of $108.00, while it has fallen to a 52-week low of $0.37. The 50-Day Moving Average of the stock is -38.31%, while the 200-Day Moving Average is calculated to be -95.36%.
Shares Statistics:
Over the past 3-months, PBM traded about 241.50K shares per day on average, while over the past 10 days, PBM traded about 154150 shares per day. A total of 0.61M shares are outstanding, with a floating share count of 0.57M. Insiders hold about 20.74% of the company’s shares, while institutions hold 93.39% stake in the company. Shares short for PBM as of 1744675200 were 190568 with a Short Ratio of 0.79, compared to 1741910400 on 194421. Therefore, it implies a Short% of Shares Outstanding of 190568 and a Short% of Float of 4.2700000000000005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
